undamentalytics Newsletter
Sign in

FMC Corp (FMC) stock

Add to watchlist

Add holding +

NYSE: FMC NYSE Fertilizers & Agricultural Chemicals Next results ~January 25, 2027

D Fundamentals grade

FMC Corp is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger).

Price vs value

Under review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger). We'll show the comparison once resolved.

FMC Corp valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter FMC files

10-Q filed October 30: FMC

Revenue for the twelve months to September 2026 was $2.81bn, down 22.0% on a year earlier, a steeper fall than the 21.3% decline a quarter earlier. Free-cash-flow margin rose to 13.1% from -9.1% a year earlier. Operating margin narrowed to -97.0% from 0.6%.

Our model value for FMC is under review, so past values are not shown until it is resolved.

Source: 10-Q filed October 30, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (1)

Where FMC stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.25bn, down 21.3% on a year earlier, a steeper fall than the 16.6% decline a quarter earlier. Free-cash-flow margin rose to 5.0% from 0.6% a year earlier. Operating margin narrowed to -61.9% from 13.4%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 1 of our 6 financial-health checks.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~January 25, 2027 (estimated)

FMC Corp's trailing-twelve-month revenue fell 22.0% year on year, with a free-cash-flow margin of 13.1%. Where it lags: revenue growth of -22.0% ranks 11 of 11 fertilizers & agricultural chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$15 per share in the base case (~$4.8–$29 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Results well short of expectations: Reported earnings per share missed the analysts' consensus estimate by 5906% in the quarter to 2026-09-30.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in FMC Corp's latest figures clears our strength thresholds.

Things to watch

  • Revenue shrinking. Revenue fell 22.0% over the last 12 months.
  • Loss-making. Operating margin is -97.0%: costs exceed revenue.
  • Margins narrowing. Operating margin is down 97.6 points on a year ago.
  • Volatile shares. Over the past year the shares showed annualised volatility of 75% and a beta of 0.7 against the S&P 500.
  • Gross margin slipping. Gross margin is down 16.2 points on a year ago.
  • Below peers: long-term debt as % of assets. Long-term debt as % of assets of 50.0% ranks 9 of 11 fertilizers & agricultural chemicals companies we cover (median 21.3%).

Latest results: FY2026 Q3

Filed October 30, 2026
Earnings per share
-$4.41 against an average estimate of $0.08: missed by 5905.7%
Revenue
$106m, down 80.5% on a year earlier
Share reaction
+38.7% in the first session after the results on October 29, 2026, against -2.1% for the S&P 500
Guidance given
fourth quarter revenue excluding India $1.04bn to $1.14bn (Fourth quarter); fourth quarter Adjusted EBITDA $210m to $230m (Fourth quarter)
Next report
October 29, 2026; average EPS estimate $0.94

FMC's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+4.8%
  • 1 week+41.0%
  • 1 month-23.0%
  • This year-52.2%
  • 1 year-56.0%
  • 5 years-92.7%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$2.8B
Operating margin
-97.0%
Net margin
-151.2%
EPS (TTM, diluted)
$-33.45

Growth

Revenue growth
−22.0%
Change in growth rate
−0.7 pts
Share count change
+1.5%

Cash

Free cash flow (TTM)
$370M
FCF margin
13.1%
Stock pay % of revenue
0.9%

Earnings

Last results
October 29, 2026
Next results (est.)
January 25, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Our research
  2. Results
  3. Guidance
  4. Leadership
  5. Agreement
  6. Announcement
  7. Results
  8. Announcement
  9. Announcement
  10. Agreement
  11. Announcement
  12. Leadership
  13. Results
  14. Dividend
  15. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

FMC Corp valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger).

Our value per share comes from a discounted-cash-flow model of FMC Corp's free cash flow after stock-based pay ( $296M, FY2026 Q3 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$26.45$38.78$65.47$51.74$82.06$96.27$93.78$108.50$56.39$45.27$13.59$6.50
Market value$3.5bn$5.2bn$8.8bn$7.0bn$10.8bn$12.6bn$12.1bn$13.7bn$7.1bn$5.7bn$1.7bn$827m
+ Net debt (− = net cash)$2.1bn$1.8bn$2.9bn$2.6bn$2.9bn$2.7bn$2.7bn$2.7bn$3.7bn$3.0bn$3.5bn$3.4bn
Enterprise value$5.6bn$7.0bn$11.7bn$9.6bn$13.8bn$15.3bn$14.8bn$16.4bn$10.7bn$8.7bn$5.2bn$4.3bn
Multiples
Price / sales 1.4x2.1x3.1x1.5x2.3x2.7x2.4x2.4x1.6x1.3x0.5x0.3x
Price / earnings 7.2x25.0x16.4x14.0x22.7x22.8x16.4x18.7x5.4x16.6x——
Price / free cash flow —18.8x45.4x25.1x23.5x18.8x15.2x26.6x—8.5x—2.2x
EV / EBITDA —19.2x45.6x10.8x14.2x14.4x12.3x12.5x14.5x12.7x——

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

56 /100

Moderate moat

How hard FMC's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 12 / 20

    Cash operating profit has been a median 9.5% of total assets over 10 years.

  • Pricing power 10 / 20

    Gross margin has been a median 41.1%, moving by 6.3 percentage points (standard deviation) across 10 years.

  • Durability 5 / 20

    Operating margin has been a median 16.8%; its worst year was -97.0%.

  • Cash conversion 12 / 20

    Free cash flow was positive in 7 of 10 years, at a median 10.5% of revenue.

  • Discipline 17 / 20

    The diluted share count fell 2.1% over five years; stock-based pay has been a median 0.5% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.20 −60% $3.3bn −6%
Next $1.39 +16% $3.5bn +8%

Next year's EPS estimate has moved −30.8% in 90 days, across 11 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −27.5% on 90 days ago. In the last 30 days, 0 analysts raised FMC Corp's forecast and 2 cut it.

Consensus EPS forecast FMC Corp, last 90 days
$1.00 $1.50 $2.00 $2.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $1.65 Current fiscal year, 60 days ago: $1.29 Current fiscal year, 30 days ago: $1.29 Current fiscal year, 7 days ago: $1.21 Current fiscal year, Now: $1.20 $1.20 Next fiscal year, 90 days ago: $2.01 Next fiscal year, 60 days ago: $1.64 Next fiscal year, 30 days ago: $1.62 Next fiscal year, 7 days ago: $1.44 Next fiscal year, Now: $1.39 $1.39

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $1.65$2.01
60 days ago $1.29$1.64
30 days ago $1.29$1.62
7 days ago $1.21$1.44
Now $1.20$1.39

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $0.08 −$4.41 −5905.7%
Jun 2026 $0.22 $0.26 +17.0%
Mar 2026 −$0.38 −$0.23 +39.6%
Dec 2025 $1.20 $1.20 −0.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, October 29, 2026
  • Full-year revenue, excluding India Full-year 2026 $2.75bn to $2.85bn Non-GAAP
    “Full-year revenue, excluding India, is expected to be in the range of $2.75 billion to $2.85 billion, a decline of 28 percent at the midpoint versus 2025, excluding India from the prior-year period.” source
  • Fourth quarter revenue excluding India Fourth quarter $1.04bn to $1.14bn Non-GAAP Lowered
    “Fourth quarter revenue excluding India lowered to a range of $1.04 billion to $1.14 billion, essentially flat at the midpoint versus 2025” source
  • Full-year Adjusted earnings per diluted share Full-year 2026 $-3.66 to $-3.50 Non-GAAP
    “Adjusted earnings per diluted share is expected to be in the range of negative $3.66 to negative $3.50, a decline of 221 percent at the midpoint versus the prior year.” source
  • Fourth quarter Adjusted earnings per diluted share Fourth quarter $0.56 to $0.70 Non-GAAP Lowered
    “Fourth quarter Adjusted earnings per diluted share lowered to a range of $0.56 to $0.70, a decline of 48 percent at the midpoint” source
  • Full year free cash flow Full year $-350m to $-150m Non-GAAP Lowered
    “Full year free cash flow now expected to be negative $350 million to negative $150 million” source
  • Full-year Adjusted EBITDA Full-year 2026 $-124m to $-104m Non-GAAP
    “Adjusted EBITDA is expected to be in the range of negative $124 million to negative $104 million, a decline of 114 percent at the midpoint versus 2025.” source
Show 1 more item
  • Fourth quarter Adjusted EBITDA Fourth quarter $210m to $230m Non-GAAP Lowered
    “Fourth quarter Adjusted EBITDA lowered to a range of $210 million to $230 million, a decline of 22 percent at the midpoint” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Our model doesn't use the consensus here: consensus revenue is 8.18x the latest quarter's run rate while reported revenue fell 80% a year: a different business (spin-off, disposal or merger) - not used.

Analyst recommendations

17 analysts, Oct 2026
Buy318%
Hold1271%
Sell212%

Monthly trend

  1. Oct 202631217
  2. Sep 20266917
  3. Aug 20265916
  4. Jul 20265815

Counts of recommendations published by analysts covering FMC Corp, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
24.4%
of tradable shares
Days to cover
5.19
at average volume
Short interest, 1 month
+14%
to October 15, 2026
Held by institutions
84%
of shares
Held by insiders
20.7%
of shares
Employees
5,500
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −56.0%

$14.78 on October 31, 2025 to $6.50

ThenNowEffect
Revenue (last 12 months) $4.1bn $3.3bn −21.3%
P/S multiple 0.4x 0.3x −44.2%
Share count 125m 125m +0.1%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years −86.8%

$49.09 on November 3, 2023 to $6.50

ThenNowEffect
Revenue (last 12 months) $5.4bn $3.3bn −39.3%
P/S multiple 1.2x 0.3x −78.4%
Share count 126m 125m +0.8%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
FMC−3%+16%−48%−20%−70%−52%
Industry peers (median)+72%+22%−16%+8%+1%+15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
FMC33%58%42%50%33%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
FMC−28%−28%−62%−28%−77%−75%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 96% from April 20, 2022 to October 28, 2026. Getting back needed a 2574% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$4.47 – $17.79
From 52-week high
−63.5%
vs 50-day average
−27.6%
vs 200-day average
−46.9%
Volatility (1 year)
75%
Beta vs S&P 500
0.68

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±18.1%
After a week
3 up, 8 down
typical move ±16.1%
After a month
1 up, 9 down
typical move ±13.7%
Results releasedNext dayS&P 500 next day5 days21 days
October 29, 2026 +38.7% −2.1% — —
October 15, 2026 −30.0% −0.8% −37.9% —
July 29, 2026 +8.1% +0.1% −1.5% −2.6%
April 29, 2026 +0.8% +1.0% −3.1% −10.5%
February 4, 2026 −14.8% −1.7% 0.0% −12.5%
October 29, 2025 −49.1% −1.1% −56.3% −53.2%
July 30, 2025 −7.2% −0.5% −12.7% −6.6%
April 30, 2025 −7.9% +0.7% −16.2% −2.8%
February 4, 2025 −34.6% +1.1% −33.6% −26.7%
October 29, 2024 +8.3% −0.1% +3.4% −3.3%
July 31, 2024 +10.0% +0.2% +4.8% +11.9%
May 6, 2024 +7.9% +1.1% +7.9% −6.5%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

FMC Corp in five measures

Fundamentals grade D
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) FMC Corp
$2.5B $3B $3.5B $4B $4.5B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $4.5B Revenue (TTM), FY24 Q1: $4.1B Revenue (TTM), FY24 Q2: $4.1B Revenue (TTM), FY24 Q3: $4.2B Revenue (TTM), FY24 Q4: $4.2B Revenue (TTM), FY25 Q1: $4.1B Revenue (TTM), FY25 Q2: $4.1B Revenue (TTM), FY25 Q3: $3.6B Revenue (TTM), FY25 Q4: $3.5B Revenue (TTM), FY26 Q1: $3.4B Revenue (TTM), FY26 Q2: $3.3B Revenue (TTM), FY26 Q3: $2.8B $2.8B

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $4.5B
FY24 Q1 $4.1B
FY24 Q2 $4.1B
FY24 Q3 $4.2B
FY24 Q4 $4.2B
FY25 Q1 $4.1B
FY25 Q2 $4.1B
FY25 Q3 $3.6B
FY25 Q4 $3.5B
FY26 Q1 $3.4B
FY26 Q2 $3.3B
FY26 Q3 $2.8B
Revenue growth, TTM YoY FMC Corp
-30% -20% -10% 0% 10% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: -22.7% Revenue growth, TTM YoY, FY24 Q1: -29.9% Revenue growth, TTM YoY, FY24 Q2: -23.8% Revenue growth, TTM YoY, FY24 Q3: -16.0% Revenue growth, TTM YoY, FY24 Q4: -5.4% Revenue growth, TTM YoY, FY25 Q1: 1.5% Revenue growth, TTM YoY, FY25 Q2: 1.2% Revenue growth, TTM YoY, FY25 Q3: -13.4% Revenue growth, TTM YoY, FY25 Q4: -18.3% Revenue growth, TTM YoY, FY26 Q1: -16.6% Revenue growth, TTM YoY, FY26 Q2: -21.3% Revenue growth, TTM YoY, FY26 Q3: -22.0% -22.0%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 -22.7%
FY24 Q1 -29.9%
FY24 Q2 -23.8%
FY24 Q3 -16.0%
FY24 Q4 -5.4%
FY25 Q1 1.5%
FY25 Q2 1.2%
FY25 Q3 -13.4%
FY25 Q4 -18.3%
FY26 Q1 -16.6%
FY26 Q2 -21.3%
FY26 Q3 -22.0%
Operating margin (TTM) FMC Corp
-100% -50% 0% 50% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 12.4% Operating margin (TTM), FY24 Q1: 8.0% Operating margin (TTM), FY24 Q2: 6.2% Operating margin (TTM), FY24 Q3: 7.0% Operating margin (TTM), FY24 Q4: 11.9% Operating margin (TTM), FY25 Q1: 11.9% Operating margin (TTM), FY25 Q2: 13.4% Operating margin (TTM), FY25 Q3: 0.6% Operating margin (TTM), FY25 Q4: -47.0% Operating margin (TTM), FY26 Q1: -51.5% Operating margin (TTM), FY26 Q2: -61.9% Operating margin (TTM), FY26 Q3: -97.0% -97.0%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 12.4%
FY24 Q1 8.0%
FY24 Q2 6.2%
FY24 Q3 7.0%
FY24 Q4 11.9%
FY25 Q1 11.9%
FY25 Q2 13.4%
FY25 Q3 0.6%
FY25 Q4 -47.0%
FY26 Q1 -51.5%
FY26 Q2 -61.9%
FY26 Q3 -97.0%
FCF margin (TTM) FMC Corp
-10% 0% 10% 20% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: -9.7% FCF margin (TTM), FY24 Q1: 7.4% FCF margin (TTM), FY24 Q2: 11.8% FCF margin (TTM), FY24 Q3: 13.3% FCF margin (TTM), FY24 Q4: 15.8% FCF margin (TTM), FY25 Q1: 6.2% FCF margin (TTM), FY25 Q2: 0.6% FCF margin (TTM), FY25 Q3: -9.1% FCF margin (TTM), FY25 Q4: -3.0% FCF margin (TTM), FY26 Q1: -4.2% FCF margin (TTM), FY26 Q2: 5.0% FCF margin (TTM), FY26 Q3: 13.1% 13.1%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 -9.7%
FY24 Q1 7.4%
FY24 Q2 11.8%
FY24 Q3 13.3%
FY24 Q4 15.8%
FY25 Q1 6.2%
FY25 Q2 0.6%
FY25 Q3 -9.1%
FY25 Q4 -3.0%
FY26 Q1 -4.2%
FY26 Q2 5.0%
FY26 Q3 13.1%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 2,826 3,116 3,036 3,410 3,131 3,259 2,491 2,539 2,879 4,728 4,610 4,642 5,045 5,802 4,487 4,246 3,467 2,815
Gross profit 883 1,051 1,101 1,268 1,201 1,211 800 931 952 1,880 2,084 2,047 2,161 2,327 1,831 1,649 1,283 618
EBITDA 462 521 687 755 627 508 −70 367 256 891 972 1,060 1,205 1,314 740 683 −1,455 −2,562
Operating income 335 387 587 639 539 415 −147 267 159 741 822 897 1,035 1,144 556 507 −1,628 −2,730
Net income 229 173 366 416 294 308 489 209 536 502 477 552 740 737 1,322 341 −2,239 −4,256
Diluted EPS $1.56 $1.18 $2.55 $3.00 $2.16 $2.29 $3.66 $1.56 $3.99 $3.69 $3.62 $4.23 $5.73 $5.81 $10.53 $2.72 −$17.88 −$33.45
Growth (year on year)
Revenue −9.3% +10.3% −2.6% +12.3% −8.2% +4.1% −23.6% +1.9% +13.4% +64.2% −2.5% +0.7% +8.7% +15.0% −22.7% −5.4% −18.3% −22.0%
EBITDA −26.1% +12.7% +31.9% +9.9% −17.0% −18.9% −113.7% — −30.2% +247.7% +9.0% +9.0% +13.8% +9.0% −43.7% −7.7% −313.0% <−999%
Operating income −33.2% +15.7% +51.7% +8.8% −15.7% −23.0% −135.3% — −40.5% +367.4% +10.9% +9.2% +15.3% +10.6% −51.4% −8.8% −421.5% —
Net income −25.0% −24.5% +112.1% +13.7% −29.4% +4.6% +59.0% −57.2% +156.2% −6.3% −4.9% +15.7% +33.9% −0.4% +79.4% −74.2% −756.4% —
Diluted EPS −61.2% −24.4% +116.1% +17.6% −28.0% +6.0% +59.8% −57.4% +155.8% −7.5% −1.9% +16.9% +35.5% +1.4% +81.2% −74.2% −757.4% —
Margins
Gross margin 31.2% 33.7% 36.2% 37.2% 38.4% 37.2% 32.1% 36.7% 33.1% 39.8% 45.2% 44.1% 42.8% 40.1% 40.8% 38.8% 37.0% 22.0%
EBITDA margin 16.3% 16.7% 22.6% 22.1% 20.0% 15.6% −2.8% 14.5% 8.9% 18.8% 21.1% 22.8% 23.9% 22.6% 16.5% 16.1% −42.0% −91.0%
Operating margin 11.8% 12.4% 19.3% 18.7% 17.2% 12.7% −5.9% 10.5% 5.5% 15.7% 17.8% 19.3% 20.5% 19.7% 12.4% 11.9% −47.0% −97.0%
Net margin 8.1% 5.5% 12.1% 12.2% 9.4% 9.4% 19.6% 8.2% 18.6% 10.6% 10.4% 11.9% 14.7% 12.7% 29.5% 8.0% −64.6% −151.2%
Free-cash-flow margin 6.5% 8.3% 11.5% 7.2% 3.0% 3.2% −21.1% 10.9% 6.7% 5.9% 10.0% 14.4% 15.8% 8.9% −9.7% 15.8% −3.0% 13.1%
Cash flow
Cash from operations 344 400 506 422 258 285 −471 369 232 363 556 737 899 660 −300 737 −6 426
Capital spending 161 142 157 177 165 182 53 91 38 83 94 67 100 142 134 68 96 56
Free cash flow 182 257 349 245 93 103 −525 278 194 280 462 670 799 518 −434 669 −103 370
Stock-based pay 11 15 15 16 14 15 15 20 21 23 26 19 18 24 26 24 24 24
Free cash flow after stock pay 171 243 334 229 79 88 −540 258 173 257 436 651 781 494 −460 645 −127 346
Balance sheet
Cash 77 162 159 77 123 110 79 64 283 134 339 569 517 572 302 357 585 736
Total debt 611 638 826 964 1,852 1,664 2,149 1,893 3,186 2,693 3,259 3,268 3,173 3,274 3,958 3,365 4,075 4,178
Net debt (negative = net cash) 534 476 667 887 1,729 1,555 2,070 1,829 2,903 2,558 2,920 2,699 2,656 2,702 3,655 3,008 3,490 3,442
Diluted shares 147m 146m 143m 139m 136m 134m 134m 135m 134m 136m 132m 131m 129m 127m 126m 125m 125m 127m
Returned to shareholders
Dividends 36 36 41 48 74 78 86 89 89 89 210 229 247 268 291 291 291 103
Buybacks 35 135 165 145 360 0 0 11 0 200 400 50 400 100 75 0 0 —
Total returned 71 171 206 193 434 78 86 100 89 289 610 279 647 368 366 291 291 103

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 4 checks passed · September 30, 2026
What it owns · $7.9bn
Short-term assets $4.6bnLonger-term assets $3.3bn
What it owes, and who funded it · $2.8bn
Short-term liabilities $2.8bnShareholders' equity $-19m
  • Short-term assets cover short-term liabilities $4.6bn of assets due within a year against $2.8bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $736m of cash against $4.2bn of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt $426m of operating cash flow against $4.2bn of debt.
  • Operating profit covers interest at least five times over Operating income of −$2.7bn against $274m of interest.

From FMC Corp's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Dividends (TTM)
$103M
Buybacks, last 3 fiscal years
$75M
Diluted share count
+1.5%
year over year
Total shareholder yield
11.9%
dividends 11.9% + buybacks 0.0% of market value
R&D spending
8.9%
of revenue
Sales & admin spending
25.1%
of revenue

Competitors: side by side with peers

Closest by revenue in fertilizers & agricultural chemicals
Last 12 months unless stated FMC SMG ICL CF UAN MOS Median
Revenue, last 12 months $2.8bn $3.5bn $7.2bn $7.7bn $677m $12.2bn $3.5bn
Revenue growth, last 12 months −22.0% 4.6% 4.6% 20.0% 17.5% 8.8% 3.7%
Revenue growth, 3-year average −17.2% −1.7% — −3.9% −4.5% −10.0% −4.2%
Revenue growth, latest quarter −80.5% 1.1% — 17.6% 20.0% −6.0% −1.2%
Gross margin 22.0% 31.8% 30.6% 42.5% 33.5% 11.0% 31.0%
Operating margin −97.0% 11.0% 8.1% 41.1% 28.1% −1.4% 3.4%
Operating margin, 3-year average −29.8% 6.8% 12.4% 32.7% 21.1% 4.2% 6.8%
Net margin −151.2% 2.1% 3.2% 27.1% 23.7% −5.2% 2.1%
Cash from operations / revenue 15.1% 10.6% 14.8% 38.5% 31.3% 3.6% 14.8%
Free-cash-flow margin 13.1% 7.6% 4.6% 24.7% 21.4% −7.7% 7.4%
Free-cash-flow margin, 3-year average 5.8% 14.4% 7.0% 26.0% 19.8% −1.3% 9.1%
Stock pay / revenue 0.9% 1.4% 0.2% 0.6% 1.3% 0.3% 0.6%
Change in share count 1.5% 3.2% 0.1% −8.6% 0.0% −0.1% 0.1%

Median of all 11 companies we cover in fertilizers & agricultural chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 fertilizers & agricultural chemicals companies
Measure Company Peer median Rank
Revenue growth Growth -22.0% 3.7% 11 of 11
Change in growth rate Growth -0.7pp -0.8pp 5 of 11
Gross margin Profitability 22.0% 31.0% 9 of 11
Operating margin Profitability -97.0% 8.1% 9 of 9
Net margin Profitability -151.2% 2.1% 11 of 11
Free-cash-flow margin Cash generation 13.1% 7.4% 4 of 11
Stock pay as % of revenue Cash generation 0.9% 0.6% 6 of 9
Long-term debt as % of assets Balance sheet 50.0% 21.3% 9 of 11
Change in share count Balance sheet 1.5% 0.1% 9 of 11

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Insecticides $1.6B 45.4% ▼ 33.9%
Herbicides $1.2B 36.0% ▼ 2.6%
Fungicides $363M 10.5% ▲ 2.9%
Plant Health $191M 5.5% ▼ 4.8%
Other $94.1M 2.7% ▲ 171.2%
Geography
Region Revenue YoY
Latin America $1.4B ▼ 2.7%
Brazil $1.1B ▲ 3.3%
North America $1.1B ▼ 6.1%
United States $923M ▼ 8.0%
EMEA $872M ▲ 4.4%
Asia $142M ▼ 83.2%

These categories overlap or exclude eliminations, so shares aren't shown.

From FMC Corp's 10-K filed February 27, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$1.5B
Institutions reporting
408
Shares held vs prior quarter
▲ 11.6%
Positions opened / closed
58 / 84

Top buyers and sellers, Q2 2026: 184 institutions bought and 238 sold ; the biggest buyer was American Century Companies Inc (+2.9M shares) and the biggest seller Morgan Stanley (−1.3M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $248M 21.5M 16.8% ▲ 15.2%
AQR Capital Management LLC $91.1M 8.0M 6.2% ▼ 13.4%
Vanguard Portfolio Management LLC $88.8M 7.7M 6.0% ▲ 0.3%
State Street Corp $75.4M 6.5M 5.1% ▲ 35.6%
Vanguard Capital Management LLC $66.2M 5.8M 4.5% ▼ 0.1%
American Century Companies Inc $58.1M 5.1M 3.9% ▲ 139.1%
D. E. Shaw & Co., Inc. $56.5M 4.9M 3.8% ▼ 18.4%
Geode Capital Management, LLC $37.7M 3.3M 2.6% ▲ 56.0%
Two Sigma Investments, LP $32.5M 2.8M 2.2% ▲ 18.8%
UBS Group AG $29M 2.5M 2.0% ▲ 94.2%
Charles Schwab Investment Management Inc $27.3M 2.4M 1.9% ▲ 20.5%
Jacobs Levy Equity Management, Inc $25.5M 2.2M 1.7% ▲ 80.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not FMC Corp's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $482,328 3 trades by 3 insiders, last 12 months Insider sales History → $15,988 1 trade by 1 insider · 0% under pre-set plans
Net ▲ $466,340 net buying
Insider Date Trade Shares Price Value
Pfeiffer Nicholas Corporate Controller September 9, 2026 Sell 1,251 $12.78 $15,988
Barry Michael F Director March 4, 2026 Buy 18,072 $13.83 $249,938
Raines John Mitchell Director November 13, 2025 Buy 7,000 $13.77 $96,390
Davidson Carol Anthony Director November 5, 2025 Buy 10,000 $13.60 $136,000

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 9 trades and filings

In the last 12 months, 1 member of Congress disclosed 0 purchases and 1 sale of FMC Corp shares.

  • Dan Newhouse(R-WA 4):Sale (full), $1,001 - $15,000, traded July 10, 2026, filed July 17, 2026
  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 31, 2025, filed November 21, 2025
  • Lisa C. McClain(R-MI 9):Sale (full), $1,001 - $15,000, traded October 30, 2025, filed November 21, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around January 25, 2027 estimated from the company's past filing pattern, not announced

  • October 29, 2026
  • October 15, 2026
  • July 29, 2026
  • April 29, 2026
  • February 4, 2026
  • October 29, 2025

Recent SEC filings

Data status

When each part of this page on FMC Corp was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

FMC Corp in brief

What does FMC Corp do?
FMC Corp is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.
What is FMC Corp's stock ticker?
FMC Corp trades under the ticker FMC on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is FMC Corp's revenue, and how fast is it growing?
Over its most recent trailing twelve months, FMC Corp reported revenue of $2.8B, 22.0% lower than a year earlier, according to its SEC filings.
What is FMC Corp's free cash flow?
FMC Corp's free-cash-flow margin is 13.1% of revenue over the trailing twelve months, ranking 4 of the 11 fertilizers & agricultural chemicals companies we cover.
Who are FMC Corp's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., AQR Capital Management LLC and Vanguard Portfolio Management LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is FMC Corp's market cap?
On November 2, 2026, FMC Corp's market capitalisation was about $827M and net debt of $3.4B. Market figures come from third-party market data and may be delayed.
Does FMC Corp pay a dividend?
Yes: FMC Corp paid $103M in dividends over the trailing twelve months, a dividend yield of 11.94%.
Who are FMC Corp's competitors?
In our Fertilizers & Agricultural Chemicals peer group, the companies closest to FMC Corp are Scotts Miracle-gro Co, ICL Group Ltd., CF Industries, CVR Partners, LP and The Mosaic Company. The side-by-side comparison below sets their revenue, margins and growth against FMC Corp's.
Are insiders buying or selling FMC Corp stock?
Over the last 12 months, FMC Corp's directors and officers reported 3 open-market purchases and 1 sales on Form 4. The insider trading page charts every trade.
When is FMC Corp's next earnings date?
Around January 25, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — FMC Corp announces its own schedule.